JavaScript NENÍ povolen !

Prosím povolte JavaScript.

Článek

FT
PubMed

Záznam pochází z PubMed

Correction to: Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma

Kaiser, Martin
Autor Kaiser, Martin Department of Haematology, The Royal Marsden Hospital, London, UK. Martin.Kaiser@icr.ac.uk Division of Molecular Pathology, The Institute of Cancer Research (ICR) and The Royal Marsden Hospital, 123 Old Brompton Road, London, SW7 3RP, UK. Martin.Kaiser@icr.ac.uk
Beksaç, Meral
Autor Beksaç, Meral Department of Hematology, Ankara University, Ankara, Turkey
Gulbrandsen, Nina
Autor Gulbrandsen, Nina Oslo Myeloma Center, Oslo University Hospital, and KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway
Schjesvold, Fredrik
Autor Schjesvold, Fredrik Oslo Myeloma Center, Oslo University Hospital, and KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway
Hájek, Roman
Autor Hájek, Roman Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic
Moreau, Philippe
Autor Moreau, Philippe Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France
de la Fuente, Felipe de Arriba
Autor de la Fuente, Felipe de Arriba Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer y Centro Regional de Hemodonación, IMIB-Arrixaca, Universidad de Murcia, Murcia, Spain
Mateos, María-Victoria
Autor Mateos, María-Victoria Department of Hematology, University Hospital of Salamanca, CIC, IBM CC, Salamanca, Spain
West, Sharon
Autor West, Sharon Department of Haematology, The Royal Marsden Hospital, London, UK
Spencer, Andrew
Autor Spencer, Andrew Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, Australia
Rajkumar, S Vincent
Autor Rajkumar, S Vincent Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
Suryanarayan, Kaveri
Autor Suryanarayan, Kaveri Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA
Czorniak, Michael
Autor Czorniak, Michael Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA
Li, Cong
Autor Li, Cong Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA
Teng, Zhaoyang
Autor Teng, Zhaoyang Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA
Labotka, Richard
Autor Labotka, Richard Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA
Dimopoulos, Meletios A
Autor Dimopoulos, Meletios A Hematology and Medical Oncology, Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Annals of hematology. 2021 Jan ; 100 (1) : 297-302.

Ann Hematol
ISSN 1432-0584 | 0939-5555
Zdroj

Status PubMed-not-MEDLINE Jazyk angličtina Země Německo Médium print

Typ dokumentu tisková chyba

Perzistentní odkaz https://www.medvik.cz/link/pmid33106909

Online Plný text

PubMed 33106909
PubMed Central PMC7852957
DOI 10.1007/s00277-020-04302-0
PII: 10.1007/s00277-020-04302-0
Knihovny.cz E-zdroje

Publikační typ
tisková chyba MeSH

Department of Haematology The Royal Marsden Hospital London UK

Department of Hematology Ankara University Ankara Turkey

Department of Hematology University Hospital Hôtel Dieu Nantes France

Department of Hematology University Hospital of Salamanca CIC IBM CC Salamanca Spain

Department of Hematooncology University Hospital Ostrava Ostrava Czech Republic

Division of Hematology Department of Internal Medicine Mayo Clinic Rochester MN USA

Division of Molecular Pathology The Institute of Cancer Research and The Royal Marsden Hospital 123 Old Brompton Road London SW7 3RP UK

Hematology and Medical Oncology Department of Clinical Therapeutics School of Medicine National and Kapodistrian University of Athens Athens Greece

Malignant Haematology and Stem Cell Transplantation Service Alfred Health Monash University Melbourne Australia

Millennium Pharmaceuticals Inc a wholly owned subsidiary of Takeda Pharmaceutical Company Limited Cambridge MA USA

Oslo Myeloma Center Oslo University Hospital and KG Jebsen Center for B Cell Malignancies University of Oslo Oslo Norway

Servicio de Hematología y Oncología Médica Hospital Universitario Morales Meseguer y Centro Regional de Hemodonación IMIB Arrixaca Universidad de Murcia Murcia Spain

Erratum pro

Ann Hematol. 2020 Aug;99(8):1793-1804. doi: 10.1007/s00277-020-04149-5. PubMed

Citace poskytuje Crossref.org

Najít záznam

v BMČ

Correction to: Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma

Najít záznam

Citační ukazatele

Možnosti archivace